# Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection

> **NCT04861922** · PHASE3 · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 100 (estimated)

## Conditions studied

- Sepsis
- Gram-Negative Bacterial Infections
- Heparin

## Interventions

- **DRUG:** Unfractionated Heparin

## Key facts

- **NCT ID:** NCT04861922
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-11
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-03-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861922, "Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04861922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*